Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools

The optimum method for isolating Campylobacter upsaliensis from stools has not been clearly defined. In a preliminary study, cefoperazone amphotericin teicoplanin (CAT) selective medium isolated six C. upsaliensis strains which were not detected using modified cefoperazone charcoal deoxycholate (mCC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical microbiology 2001-07, Vol.39 (7), p.2713-2716
Hauptverfasser: BYRNE, Catherine, DOHERTY, Deirdre, MOONEY, Adele, BYRNE, Margaret, WOODWARD, David, JOHNSON, Wendy, RODGERS, Frank, BOURKE, Billy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2716
container_issue 7
container_start_page 2713
container_title Journal of clinical microbiology
container_volume 39
creator BYRNE, Catherine
DOHERTY, Deirdre
MOONEY, Adele
BYRNE, Margaret
WOODWARD, David
JOHNSON, Wendy
RODGERS, Frank
BOURKE, Billy
description The optimum method for isolating Campylobacter upsaliensis from stools has not been clearly defined. In a preliminary study, cefoperazone amphotericin teicoplanin (CAT) selective medium isolated six C. upsaliensis strains which were not detected using modified cefoperazone charcoal deoxycholate (mCCDA). In order to identify the factors that underlie the superiority of CAT over mCCDA for isolating C. upsaliensis, we examined the effect of incubation time and antibiotic content of culture media on the growth of C. upsaliensis isolates using semiquantitative methods. The recovery of a subgroup of C. upsaliensis isolates from seeded stool specimens was also evaluated. Differences in growth of C. upsaliensis on CAT and mCCDA were modest and were not explained by the antibiotic profiles of the two media. Recovery of C. upsaliensis from spiked human feces on CAT was superior to that on mCCDA at lower concentrations of organisms (10(3) CFU/ml). We conclude that although CAT is more suitable than mCCDA for the isolation of C. upsaliensis from stools, the superiority of CAT for detecting this organism is not accounted for by the antibiotic composition of the medium.
doi_str_mv 10.1128/JCM.39.7.2713-2716.2001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_88219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70992951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-edc3da0f2eeb608d9b69fc7682488c08b6d1085ea6e42862c1ef5f73eea8b72c3</originalsourceid><addsrcrecordid>eNqFkcuO1DAQRS0EYpqBX4BsYJfgR-KHxIZp8dQgNiCxsxx3edrIiYPtIDVfj6NpMbBiU1WqOrfs0kXoGcEdIVS-_Lj_1DHViY4KwtoaeEcxJvfQjmAlW87xt_toh7EaWkKYuECPcv5egb4fhofogpCeCo7ZDq1XJvvcRNeUIzR5XSD5mHw5bS0LLtaG-RVnaMy0HGOpY-vnpoC3cQlmrrWLqfE5BlP8fNPsK3cKcTS2ss26ZBM8zNsbLsWpySXGkB-jB86EDE_O-RJ9ffvmy_59e_353Yf96-vW9oKWFg6WHQx2FGDkWB7UyJWzgkvaS2mxHPmBYDmA4dBTyakl4AYnGICRo6CWXaJXt3uXdZzqNphLMkEvyU8mnXQ0Xv87mf1R38SfWkpKVJW_OMtT_LFCLnry2UKod0NcsxZYKaoG8l-QCEU55qKC4ha0KeacwP35C8F6c1ZXZzVTWujN2S1wvTlblU__PuVOd7ayAs_PgMnWBJfMbH2-43rCsRKK_QbeQrHq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17926067</pqid></control><display><type>article</type><title>Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>BYRNE, Catherine ; DOHERTY, Deirdre ; MOONEY, Adele ; BYRNE, Margaret ; WOODWARD, David ; JOHNSON, Wendy ; RODGERS, Frank ; BOURKE, Billy</creator><creatorcontrib>BYRNE, Catherine ; DOHERTY, Deirdre ; MOONEY, Adele ; BYRNE, Margaret ; WOODWARD, David ; JOHNSON, Wendy ; RODGERS, Frank ; BOURKE, Billy</creatorcontrib><description>The optimum method for isolating Campylobacter upsaliensis from stools has not been clearly defined. In a preliminary study, cefoperazone amphotericin teicoplanin (CAT) selective medium isolated six C. upsaliensis strains which were not detected using modified cefoperazone charcoal deoxycholate (mCCDA). In order to identify the factors that underlie the superiority of CAT over mCCDA for isolating C. upsaliensis, we examined the effect of incubation time and antibiotic content of culture media on the growth of C. upsaliensis isolates using semiquantitative methods. The recovery of a subgroup of C. upsaliensis isolates from seeded stool specimens was also evaluated. Differences in growth of C. upsaliensis on CAT and mCCDA were modest and were not explained by the antibiotic profiles of the two media. Recovery of C. upsaliensis from spiked human feces on CAT was superior to that on mCCDA at lower concentrations of organisms (10(3) CFU/ml). We conclude that although CAT is more suitable than mCCDA for the isolation of C. upsaliensis from stools, the superiority of CAT for detecting this organism is not accounted for by the antibiotic composition of the medium.</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.39.7.2713-2716.2001</identifier><identifier>PMID: 11427603</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Amphotericin B - pharmacology ; Animals ; Anti-Bacterial Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Bacteriology ; Biological and medical sciences ; Campylobacter - drug effects ; Campylobacter - growth &amp; development ; Campylobacter - isolation &amp; purification ; Campylobacter Infections - microbiology ; Campylobacter Infections - veterinary ; Campylobacter upsaliensis ; Cat Diseases - microbiology ; Cats ; Cefoperazone - pharmacology ; Child ; Culture Media - chemistry ; Dog Diseases - microbiology ; Dogs ; Feces - microbiology ; Fundamental and applied biological sciences. Psychology ; Human bacterial diseases ; Humans ; Infectious diseases ; Medical sciences ; Microbial Sensitivity Tests - methods ; Microbiology ; Pharmacology. Drug treatments ; Rabbits ; Teicoplanin - pharmacology</subject><ispartof>Journal of clinical microbiology, 2001-07, Vol.39 (7), p.2713-2716</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright © 2001, American Society for Microbiology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-edc3da0f2eeb608d9b69fc7682488c08b6d1085ea6e42862c1ef5f73eea8b72c3</citedby><cites>FETCH-LOGICAL-c472t-edc3da0f2eeb608d9b69fc7682488c08b6d1085ea6e42862c1ef5f73eea8b72c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC88219/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC88219/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,3177,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14160979$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11427603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BYRNE, Catherine</creatorcontrib><creatorcontrib>DOHERTY, Deirdre</creatorcontrib><creatorcontrib>MOONEY, Adele</creatorcontrib><creatorcontrib>BYRNE, Margaret</creatorcontrib><creatorcontrib>WOODWARD, David</creatorcontrib><creatorcontrib>JOHNSON, Wendy</creatorcontrib><creatorcontrib>RODGERS, Frank</creatorcontrib><creatorcontrib>BOURKE, Billy</creatorcontrib><title>Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools</title><title>Journal of clinical microbiology</title><addtitle>J Clin Microbiol</addtitle><description>The optimum method for isolating Campylobacter upsaliensis from stools has not been clearly defined. In a preliminary study, cefoperazone amphotericin teicoplanin (CAT) selective medium isolated six C. upsaliensis strains which were not detected using modified cefoperazone charcoal deoxycholate (mCCDA). In order to identify the factors that underlie the superiority of CAT over mCCDA for isolating C. upsaliensis, we examined the effect of incubation time and antibiotic content of culture media on the growth of C. upsaliensis isolates using semiquantitative methods. The recovery of a subgroup of C. upsaliensis isolates from seeded stool specimens was also evaluated. Differences in growth of C. upsaliensis on CAT and mCCDA were modest and were not explained by the antibiotic profiles of the two media. Recovery of C. upsaliensis from spiked human feces on CAT was superior to that on mCCDA at lower concentrations of organisms (10(3) CFU/ml). We conclude that although CAT is more suitable than mCCDA for the isolation of C. upsaliensis from stools, the superiority of CAT for detecting this organism is not accounted for by the antibiotic composition of the medium.</description><subject>Amphotericin B - pharmacology</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Campylobacter - drug effects</subject><subject>Campylobacter - growth &amp; development</subject><subject>Campylobacter - isolation &amp; purification</subject><subject>Campylobacter Infections - microbiology</subject><subject>Campylobacter Infections - veterinary</subject><subject>Campylobacter upsaliensis</subject><subject>Cat Diseases - microbiology</subject><subject>Cats</subject><subject>Cefoperazone - pharmacology</subject><subject>Child</subject><subject>Culture Media - chemistry</subject><subject>Dog Diseases - microbiology</subject><subject>Dogs</subject><subject>Feces - microbiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests - methods</subject><subject>Microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Teicoplanin - pharmacology</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuO1DAQRS0EYpqBX4BsYJfgR-KHxIZp8dQgNiCxsxx3edrIiYPtIDVfj6NpMbBiU1WqOrfs0kXoGcEdIVS-_Lj_1DHViY4KwtoaeEcxJvfQjmAlW87xt_toh7EaWkKYuECPcv5egb4fhofogpCeCo7ZDq1XJvvcRNeUIzR5XSD5mHw5bS0LLtaG-RVnaMy0HGOpY-vnpoC3cQlmrrWLqfE5BlP8fNPsK3cKcTS2ss26ZBM8zNsbLsWpySXGkB-jB86EDE_O-RJ9ffvmy_59e_353Yf96-vW9oKWFg6WHQx2FGDkWB7UyJWzgkvaS2mxHPmBYDmA4dBTyakl4AYnGICRo6CWXaJXt3uXdZzqNphLMkEvyU8mnXQ0Xv87mf1R38SfWkpKVJW_OMtT_LFCLnry2UKod0NcsxZYKaoG8l-QCEU55qKC4ha0KeacwP35C8F6c1ZXZzVTWujN2S1wvTlblU__PuVOd7ayAs_PgMnWBJfMbH2-43rCsRKK_QbeQrHq</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>BYRNE, Catherine</creator><creator>DOHERTY, Deirdre</creator><creator>MOONEY, Adele</creator><creator>BYRNE, Margaret</creator><creator>WOODWARD, David</creator><creator>JOHNSON, Wendy</creator><creator>RODGERS, Frank</creator><creator>BOURKE, Billy</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010701</creationdate><title>Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools</title><author>BYRNE, Catherine ; DOHERTY, Deirdre ; MOONEY, Adele ; BYRNE, Margaret ; WOODWARD, David ; JOHNSON, Wendy ; RODGERS, Frank ; BOURKE, Billy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-edc3da0f2eeb608d9b69fc7682488c08b6d1085ea6e42862c1ef5f73eea8b72c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amphotericin B - pharmacology</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Campylobacter - drug effects</topic><topic>Campylobacter - growth &amp; development</topic><topic>Campylobacter - isolation &amp; purification</topic><topic>Campylobacter Infections - microbiology</topic><topic>Campylobacter Infections - veterinary</topic><topic>Campylobacter upsaliensis</topic><topic>Cat Diseases - microbiology</topic><topic>Cats</topic><topic>Cefoperazone - pharmacology</topic><topic>Child</topic><topic>Culture Media - chemistry</topic><topic>Dog Diseases - microbiology</topic><topic>Dogs</topic><topic>Feces - microbiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests - methods</topic><topic>Microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Teicoplanin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BYRNE, Catherine</creatorcontrib><creatorcontrib>DOHERTY, Deirdre</creatorcontrib><creatorcontrib>MOONEY, Adele</creatorcontrib><creatorcontrib>BYRNE, Margaret</creatorcontrib><creatorcontrib>WOODWARD, David</creatorcontrib><creatorcontrib>JOHNSON, Wendy</creatorcontrib><creatorcontrib>RODGERS, Frank</creatorcontrib><creatorcontrib>BOURKE, Billy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BYRNE, Catherine</au><au>DOHERTY, Deirdre</au><au>MOONEY, Adele</au><au>BYRNE, Margaret</au><au>WOODWARD, David</au><au>JOHNSON, Wendy</au><au>RODGERS, Frank</au><au>BOURKE, Billy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools</atitle><jtitle>Journal of clinical microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>39</volume><issue>7</issue><spage>2713</spage><epage>2716</epage><pages>2713-2716</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><abstract>The optimum method for isolating Campylobacter upsaliensis from stools has not been clearly defined. In a preliminary study, cefoperazone amphotericin teicoplanin (CAT) selective medium isolated six C. upsaliensis strains which were not detected using modified cefoperazone charcoal deoxycholate (mCCDA). In order to identify the factors that underlie the superiority of CAT over mCCDA for isolating C. upsaliensis, we examined the effect of incubation time and antibiotic content of culture media on the growth of C. upsaliensis isolates using semiquantitative methods. The recovery of a subgroup of C. upsaliensis isolates from seeded stool specimens was also evaluated. Differences in growth of C. upsaliensis on CAT and mCCDA were modest and were not explained by the antibiotic profiles of the two media. Recovery of C. upsaliensis from spiked human feces on CAT was superior to that on mCCDA at lower concentrations of organisms (10(3) CFU/ml). We conclude that although CAT is more suitable than mCCDA for the isolation of C. upsaliensis from stools, the superiority of CAT for detecting this organism is not accounted for by the antibiotic composition of the medium.</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>11427603</pmid><doi>10.1128/JCM.39.7.2713-2716.2001</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0095-1137
ispartof Journal of clinical microbiology, 2001-07, Vol.39 (7), p.2713-2716
issn 0095-1137
1098-660X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_88219
source American Society for Microbiology; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Amphotericin B - pharmacology
Animals
Anti-Bacterial Agents - pharmacology
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Bacteriology
Biological and medical sciences
Campylobacter - drug effects
Campylobacter - growth & development
Campylobacter - isolation & purification
Campylobacter Infections - microbiology
Campylobacter Infections - veterinary
Campylobacter upsaliensis
Cat Diseases - microbiology
Cats
Cefoperazone - pharmacology
Child
Culture Media - chemistry
Dog Diseases - microbiology
Dogs
Feces - microbiology
Fundamental and applied biological sciences. Psychology
Human bacterial diseases
Humans
Infectious diseases
Medical sciences
Microbial Sensitivity Tests - methods
Microbiology
Pharmacology. Drug treatments
Rabbits
Teicoplanin - pharmacology
title Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T07%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Basis%20of%20the%20superiority%20of%20cefoperazone%20amphotericin%20teicoplanin%20for%20isolating%20Campylobacter%20upsaliensis%20from%20stools&rft.jtitle=Journal%20of%20clinical%20microbiology&rft.au=BYRNE,%20Catherine&rft.date=2001-07-01&rft.volume=39&rft.issue=7&rft.spage=2713&rft.epage=2716&rft.pages=2713-2716&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/JCM.39.7.2713-2716.2001&rft_dat=%3Cproquest_pubme%3E70992951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17926067&rft_id=info:pmid/11427603&rfr_iscdi=true